Guarantor Financial Information (Tables)

12 Months Ended

Dec. 31, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Balance Sheet

	Condensed Consolidating Balance Sheet
(As of December 31, 2016) (In millions)	Shire plc (Parent Guarantor)		SAIIDAC (SAIIDAC Notes Subsidiary Issuer)		Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)		Non-Guarantor Non-Issuer Subsidiaries		Non-Guarantor Subsidiaries of Baxalta Notes		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	—	$	41.7	$	487.1	$	487.1	$	—		$	528.8
Restricted cash	—		—		—		25.6		25.6		—			25.6
Accounts receivable, net	—		—		—		2,616.5		2,616.5		—			2,616.5
Inventories	—		—		—		3,562.3		3,562.3		—			3,562.3
Prepaid expenses and other current assets	1.8		—		97.1		707.4		707.4		—			806.3
Intercompany receivables	—		120.5		—		5,154.4		5,274.9		(5,274.9		)	—
Short-term intercompany loan receivable	—		2,594.8		—		—		2,594.8		(2,594.8		)	—
Total current assets	1.8		2,715.3		138.8		12,553.3		15,268.6		(7,869.7		)	7,539.5
Investments	35,656.1		—		34,644.2		12,571.8		12,571.8		(82,680.5		)	191.6
Property, plant and equipment, net	—		—		27.4		6,442.2		6,442.2		—			6,469.6
Goodwill	—		—		—		17,888.2		17,888.2		—			17,888.2
Intangible assets, net	—		—		—		34,697.5		34,697.5		—			34,697.5
Deferred tax asset	—		—		273.0		96.7		96.7		(273.0		)	96.7
Long-term intercompany loan receivable	—		14,431.0		480.7		—		14,431.0		(14,911.7		)	—
Other non-current assets	3.9		—		33.8		114.6		114.6		—			152.3
Total assets	$	35,661.8	$	17,146.3	$	35,597.9	$	84,364.3	$	101,510.6	$	(105,734.9	)	$	67,035.4
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	1.3	$	85.7	$	20.0	$	4,205.4	$	4,291.1	$	—		$	4,312.4
Short-term borrowings and capital lease obligations	450.0		2,594.8		—		23.2		2,618.0		—			3,068.0
Intercompany payables	5,247.1		—		27.8		—		—		(5,274.9		)	—
Short-term intercompany loans payable	—		—		—		2,594.8		2,594.8		(2,594.8		)	—
Other current liabilities	—		—		64.6		298.3		298.3		—			362.9
Total current liabilities	5,698.4		2,680.5		112.4		7,121.7		9,802.2		(7,869.7		)	7,743.3
Long-term borrowings and capital lease obligations	—		14,431.0		5,063.7		405.1		14,836.1		—			19,899.8
Deferred tax liability	—		—		—		8,595.7		8,595.7		(273.0		)	8,322.7
Long-term intercompany loans payable	610.1		—		—		14,301.6		14,301.6		(14,911.7		)	—
Other non-current liabilities	405.3		—		61.7		1,654.6		1,654.6		—			2,121.6
Total liabilities	6,713.8		17,111.5		5,237.8		32,078.7		49,190.2		(23,054.4		)	38,087.4
Total equity	28,948.0		34.8		30,360.1		52,285.6		52,320.4		(82,680.5		)	28,948.0
Total liabilities and equity	$	35,661.8	$	17,146.3	$	35,597.9	$	84,364.3	$	101,510.6	$	(105,734.9	)	$	67,035.4

	Condensed Consolidating Balance Sheet
(As of December 31, 2015) (In millions)	Shire plc (Parent Guarantor)		SAIIDAC (SAIIDAC Notes Subsidiary Issuer)			Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)		Non-Guarantor Non-Issuer Subsidiaries		Non-Guarantor Subsidiaries of Baxalta Notes		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	—		$	—	$	135.5	$	135.5	$	—		$	135.5
Restricted cash	—		—			—		86.0		86.0		—			86.0
Accounts receivable, net	—		—			—		1,201.2		1,201.2		—			1,201.2
Inventories	—		—			—		635.4		635.4		—			635.4
Prepaid expenses and other current assets	1.9		9.6			—		185.9		195.5		—			197.4
Intercompany receivables	—		—			—		3,164.9		3,164.9		(3,164.9		)	—
Total current assets	1.9		9.6			—		5,408.9		5,418.5		(3,164.9		)	2,255.5
Investments	14,477.2		—			—		50.8		50.8		(14,477.2		)	50.8
Property, plant and equipment, net	—		—			—		828.1		828.1		—			828.1
Goodwill	—		—			—		4,147.8		4,147.8		—			4,147.8
Intangible assets, net	—		—			—		9,173.3		9,173.3		—			9,173.3
Deferred tax asset	—		—			—		121.0		121.0		—			121.0
Other non-current assets	5.3		8.3			—		19.7		28.0		—			33.3
Total assets	$	14,484.4	$	17.9		$	—	$	19,749.6	$	19,767.5	$	(17,642.1	)	$	16,609.8
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	10.0	$	—		$	—	$	2,040.6	$	2,040.6	$	—		$	2,050.6
Short-term borrowings and capital lease obligations	1,500.0		—			—		12.7		12.7		—			1,512.7
Intercompany payables	3,145.3		19.6			—		—		19.6		(3,164.9		)	—
Other current liabilities	—		—			—		142.8		142.8		—			142.8
Total current liabilities	4,655.3		19.6			—		2,196.1		2,215.7		(3,164.9		)	3,706.1
Long-term borrowings and capital lease obligations	—		—			—		82.1		82.1		—			82.1
Deferred tax liability	—		—			—		2,205.9		2,205.9		—			2,205.9
Other non-current liabilities	—		—			—		786.6		786.6		—			786.6
Total liabilities	4,655.3		19.6			—		5,270.7		5,290.3		(3,164.9		)	6,780.7
Total equity	9,829.1		(1.7		)	—		14,478.9		14,477.2		(14,477.2		)	9,829.1
Total liabilities and equity	$	14,484.4	$	17.9		$	—	$	19,749.6	$	19,767.5	$	(17,642.1	)	$	16,609.8

Condensed Income Statement

	Condensed Consolidating Statements of Operations
For the year ended December 31, 2016 (In millions)	Shire plc (Parent Guarantor)			SAIIDAC (SAIIDAC Notes Subsidiary Issuer)			Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)			Non-Guarantor Non-Issuer Subsidiaries			Non-Guarantor Subsidiaries of Baxalta Notes			Eliminations		Consolidated
Revenues:
Product sales	$	—		$	—		$	—		$	10,885.8		$	10,885.8		$	—	$	10,885.8
Royalties and other revenues	—			—			—			510.8			510.8			—		510.8
Total revenues	—			—			—			11,396.6			11,396.6			—		11,396.6
Costs and expenses:
Cost of sales	—			—			—			3,816.5			3,816.5			—		3,816.5
Research and development	—			—			0.4			1,439.4			1,439.4			—		1,439.8
Selling, general and administrative	59.8			—			29.4			2,926.0			2,926.0			—		3,015.2
Amortization of acquired intangible assets	—			—			—			1,173.4			1,173.4			—		1,173.4
Integration and acquisition costs	—			—			302.0			581.9			581.9			—		883.9
Reorganization costs	—			—			—			121.4			121.4			—		121.4
Gain on sale of product rights	—			—			—			(16.5		)	(16.5		)	—		(16.5		)
Total operating expenses, net	59.8			—			331.8			10,042.1			10,042.1			—		10,433.7
Operating income / (loss) from continuing operations	(59.8		)	—			(331.8		)	1,354.5			1,354.5			—		962.9
Interest income / (expense), net	(100.6		)	36.5			(45.1		)	(342.0		)	(305.5		)	—		(451.2		)
Other expense, net	0.9			—			2.7			(29.2		)	(29.2		)	—		(25.6		)
Total other income / (expense), net	(99.7		)	36.5			(42.4		)	(371.2		)	(334.7		)	—		(476.8		)
Income / (loss) from continuing operations before income taxes and equity in (losses)/earnings of equity method investees	(159.5		)	36.5			(374.2		)	983.3			1,019.8			—		486.1
Income taxes	4.3			(9.1		)	88.9			42.0			32.9			—		126.1
Equity in income / (losses) of equity method investees, net of taxes	482.6			—			(657.5		)	(8.7		)	(8.7		)	174.9		(8.7		)
Income / (loss) from continuing operations, net of taxes	327.4			27.4			(942.8		)	1,016.6			1,044.0			174.9		603.5
Loss from discontinued operations, net of taxes	—			—			—			(276.1		)	(276.1		)	—		(276.1		)
Net income / (loss)	327.4			27.4			(942.8		)	740.5			767.9			174.9		327.4
Comprehensive (loss) / income	$	(986.4	)	$	27.4		$	(2,148.9	)	$	(572.9	)	$	(545.5	)	$	2,694.4	$	(986.4	)

	Condensed Consolidating Statements of Operations
For the year ended December 31, 2015 (In millions)	Shire plc (Parent Guarantor)			SAIIDAC (SAIIDAC Notes Subsidiary Issuer)			Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)		Non-Guarantor Non-Issuer Subsidiaries			Non-Guarantor Subsidiaries of Baxalta Notes			Eliminations			Consolidated
Revenues:
Product sales	$	—		$	—		$	—	$	6,099.9		$	6,099.9		$	—		$	6,099.9
Royalties and other revenues	—			—			—		316.8			$	316.8		—			316.8
Total revenues	—			—			—		6,416.7			6,416.7			—			6,416.7
Costs and expenses:
Cost of sales	—			—			—		969.0			$	969.0		—			969.0
Research and development	—			—			—		1,564.0			$	1,564.0		—			1,564.0
Selling, general and administrative	24.9			—			—		1,816.2			$	1,816.2		1.4			1,842.5
Amortization of acquired intangible assets	—			—			—		498.7			$	498.7		—			498.7
Integration and acquisition costs	—			—			—		39.8			$	39.8		—			39.8
Reorganization costs	—			—			—		97.9			$	97.9		—			97.9
Gain on sale of product rights	—			—			—		(14.7		)	$	(14.7	)	—			(14.7		)
Total operating expenses, net	24.9			—			—		4,970.9			4,970.9			1.4			4,997.2
Operating (loss) / income from continuing operations	(24.9		)	—			—		1,445.8			1,445.8			(1.4		)	1,419.5
Interest (expense) / income, net	(63.6		)	(1.7		)	—		27.9			$	26.2		—			(37.4		)
Other income / (expense), net	0.9			—			—		2.8			$	2.8		—			3.7
Total other (expense) / income, net	(62.7		)	(1.7		)	—		30.7			29.0			—			(33.7		)
(Loss) / income from continuing operations before income taxes and equity in (losses)/earnings of equity method investees	(87.6		)	(1.7		)	—		1,476.5			1,474.8			(1.4		)	1,385.8
Income taxes	2.9			—			—		(49.0		)	(49.0		)	—			(46.1		)
Equity in income / (losses) of equity method investees, net of taxes	1,388.1			—			—		(2.2		)	(2.2		)	(1,388.1		)	(2.2		)
Income / (loss) from continuing operations, net of taxes	1,303.4			(1.7		)	—		1,425.3			1,423.6			(1,389.5		)	1,337.5
Loss from discontinued operations, net of taxes	—			—			—		(34.1		)	(34.1		)	—			(34.1		)
Net income / (loss)	1,303.4			(1.7		)	—		1,391.2			1,389.5			(1,389.5		)	1,303.4
Comprehensive income/(loss)	$	1,151.1		$	(1.7	)	$	—	$	1,238.9		$	1,237.2		$	(1,237.2	)	$	1,151.1

	Condensed Consolidating Statements of Operations
(For the year ended December 31, 2014) (In millions)	Shire plc (Parent Guarantor)			SAIIDAC (SAIIDAC Notes Subsidiary Issuer)		Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)		Non-Guarantor Non-Issuer Subsidiaries			Non-Guarantor Subsidiaries of Baxalta Notes			Eliminations			Consolidated
Revenues:
Product sales	$	—		$	—	$	—	$	5,830.4		$	5,830.4		$	—		$	5,830.4
Royalties and other revenues	—			—		—		191.7			191.7			—			191.7
Total revenues	—			—		—		6,022.1			6,022.1			—			6,022.1
Costs and expenses:
Cost of sales	—			—		—		979.3			979.3			—			979.3
Research and development	—			—		—		1,067.5			1,067.5			—			1,067.5
Selling, general and administrative	109.4			—		—		1,671.2			1,671.2			1.4			1,782.0
Amortization of acquired intangible assets	—			—		—		243.8			243.8			—			243.8
Integration and acquisition costs	—			—		—		158.8			158.8			—			158.8
Reorganization costs	—			—		—		180.9			180.9			—			180.9
Gain on sale of product rights	—			—		—		(88.2		)	(88.2		)	—			(88.2		)
Total operating expenses, net	109.4			—		—		4,213.3			4,213.3			1.4			4,324.1
Operating (loss) / income from continuing operations	(109.4		)	—		—		1,808.8			1,808.8			(1.4		)	1,698.0
Interest (expense) / income, net	(42.8		)	—		—		36.7			36.7			—			(6.1		)
Other income, net	0.3			—		—		8.6			8.6			—			8.9
Receipt of break fee	1,635.4			—		—		—			—			—			1,635.4
Total other income, net	1,592.9			—		—		45.3			45.3			—			1,638.2
Income / (loss) from continuing operations before income taxes and equity in (losses)/earnings of equity method investees	1,483.5			—		—		1,854.1			1,854.1			(1.4		)	3,336.2
Income taxes	2.2			—		—		(58.3		)	(58.3		)	—			(56.1		)
Equity in income / (losses) of equity method investees, net of taxes	1,919.8			—		—		2.7			2.7			(1,919.8		)	2.7
Income / (loss) from continuing operations, net of taxes	3,405.5			—		—		1,798.5			1,798.5			(1,921.2		)	3,282.8
Income from discontinued operations, net of taxes	—			—		—		122.7			122.7			—			122.7
Net income / (loss)	3,405.5			—		—		1,921.2			1,921.2			(1,921.2		)	3,405.5
Comprehensive income / (loss)	$	3,263.8		$	—	$	—	$	1,779.5		$	1,779.5		$	(1,779.5	)	$	3,263.8

Condensed Cash Flow Statement

	Condensed Consolidating Statement of Cash Flows
(For the year ended December 31, 2016) (In millions)	Shire plc (Parent Guarantor)			SAIIDAC (SAIIDAC Notes Subsidiary Issuer)			Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)			Non-Guarantor Non-Issuer Subsidiaries			Non-Guarantor Subsidiaries of Baxalta Notes			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net cash (used in) / provided by operating activities	$	(136.9	)	$	232.8		$	(51.0	)	$	2,614.0		$	2,846.8		$	—		$	2,658.9
CASH FLOWS FROM INVESTING ACTIVITIES:
Transactions with subsidiaries	(2,890.0		)	(18,228.8		)	(480.7		)	(4,707.3		)	(22,936.1		)	26,306.8			—
Movements in restricted cash	—			—			—			62.8			62.8			—			62.8
Purchases of subsidiary undertakings and businesses, net of cash acquired	—			—			—			(17,476.2		)	(17,476.2		)	—			(17,476.2		)
Purchases of non-current investments and PP&E	—			—			(11.1		)	(637.6		)	(637.6		)	—			(648.7		)
Proceeds received on sale of product rights	—			—			—			10.9			10.9			—			10.9
Proceeds from disposal of non-current investments and PP&E	—			—			—			0.9			0.9			—			0.9
Other, net	—			—			—			(41.9		)	(41.9		)	—			(41.9		)
Net cash (used in) / provided by investing activities	(2,890.0		)	(18,228.8		)	(491.8		)	(22,788.4		)	(41,017.2		)	26,306.8			(18,092.2		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving line of credit, long term and short term borrowings	2,355.0			30,079.9			—			8.5			30,088.4			—			32,443.4
Repayment of revolving line of credit, long term and short term borrowings	(3,405.0		)	(13,009.2		)	—			9.9			(12,999.3		)	—			(16,404.3		)
Proceeds from intercompany borrowings	4,077.8			1,097.6			521.9			20,609.5			21,707.1			(26,306.8		)	—
Payment of dividend	(20.7		)	—			—			(150.6		)	(150.6		)	—			(171.3		)
Debt issuance costs	—			(172.3		)	—			—			(172.3		)	—			(172.3		)
Contingent consideration payments	—			—			—			(8.0		)	(8.0		)	—			(8.0		)
Proceeds from exercise of options	19.8			—			92.7			16.5			16.5			—			129.0
Other, net	—			—			(30.1		)	39.4			39.4			—			9.3
Net cash provided by / (used in) financing activities	3,026.9			17,996.0			584.5			20,525.2			38,521.2			(26,306.8		)	15,825.8
Effect of foreign exchange rate changes on cash and cash equivalents	—			—			—			0.8			0.8			—			0.8
Net increase in cash and cash equivalents	—			—			41.7			351.6			351.6			—			393.3
Cash and cash equivalents at beginning of period	—			—			—			135.5			135.5			—			135.5
Cash and cash equivalents at end of period	$	—		$	—		$	41.7		$	487.1		$	487.1		$	—		$	528.8

	Condensed Consolidating Statement of Cash Flows
(For the year ended December 31, 2015) (In millions)	Shire plc (Parent Guarantor)			SAIIDAC (SAIIDAC Notes Subsidiary Issuer)		Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)		Non-Guarantor Non-Issuer Subsidiaries			Non-Guarantor Subsidiaries of Baxalta Notes			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net cash (used in) / provided by operating activities	$	(133.5	)	$	—	$	—	$	2,470.5		$	2,470.5		$	—		$	2,337.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Transactions with subsidiaries	(3,570.0		)	—		—		(3,048.2		)	(3,048.2		)	6,618.2			—
Movements in restricted cash	—			—		—		(32.0		)	(32.0		)	—			(32.0		)
Purchases of subsidiary undertakings and businesses, net of cash acquired	—			—		—		(5,553.4		)	(5,553.4		)	—			(5,553.4		)
Purchases of non-current investments and PP&E	—			—		—		(124.2		)	(124.2		)	—			(124.2		)
Proceeds from short-term investments	—			—		—		67.0			67.0			—			67.0
Proceeds received on sale of product rights	—			—		—		17.5			17.5			—			17.5
Proceeds from disposal of non-current investments and PP&E	—			—		—		18.7			18.7			—			18.7
Other, net	—			—		—		(13.5		)	(13.5		)	—			(13.5		)
Net cash provided by / (used in) investing activities	(3,570.0		)	—		—		(8,668.1		)	(8,668.1		)	6,618.2			(5,619.9		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving line of credit, long term and short term borrowings	3,760.0			—		—		0.8			0.8			—			3,760.8
Repayment of revolving line of credit, long term and short term borrowings	(3,110.0		)	—		—		(0.9		)	(0.9		)	—			(3,110.9		)
Proceeds from intercompany borrowings	3,048.2			—		—		3,570.0			3,570.0			(6,618.2		)	—
Payment of dividend	(6.8		)	—		—		(127.6		)	(127.6		)	—			(134.4		)
Debt issuance costs	(4.5		)	—		—		(19.6		)	(19.6		)	—			(24.1		)
Contingent consideration payments	—			—		—		(101.2		)	(101.2		)	—			(101.2		)
Proceeds from exercise of options	16.6			—		—		—			—			—			16.6
Other, net	—			—		—		32.2			32.2			—			32.2
Net cash provided by / (used in) financing activities	3,703.5			—		—		3,353.7			3,353.7			(6,618.2		)	439.0
Effect of foreign exchange rate changes on cash and cash equivalents	—			—		—		(3.0		)	(3.0		)	—			(3.0		)
Net decrease in cash and cash equivalents	—			—		—		(2,846.9		)	(2,846.9		)	—			(2,846.9		)
Cash and cash equivalents at beginning of period	—			—		—		2,982.4			2,982.4			—			2,982.4
Cash and cash equivalents at end of period	$	—		$	—	$	—	$	135.5		$	135.5		$	—		$	135.5

	Condensed Consolidating Statement of Cash Flows
(For the year ended December 31, 2014) (In millions)	Shire plc (Parent Guarantor)			SAIIDAC (SAIIDAC Notes Subsidiary Issuer)		Baxalta Inc. (Baxalta Notes Subsidiary Issuer and SAIIDAC Notes Subsidiary Guarantor)		Non-Guarantor Non-Issuer Subsidiaries			Non-Guarantor Subsidiaries of Baxalta Notes			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net cash provided by / (used in) operating activities	$	1,512.6		$	—	$	—	$	2,715.8		$	2,715.8		$	—		$	4,228.4
CASH FLOWS FROM INVESTING ACTIVITIES:
Transactions with subsidiaries	(1,900.0		)	—		—		458.3			458.3			1,441.7			—
Movements in restricted cash	—			—		—		(32.6		)	(32.6		)	—			(32.6		)
Purchases of subsidiary undertakings and businesses, net of cash acquired	—			—		—		(4,104.4		)	(4,104.4		)	—			(4,104.4		)
Purchases of non-current investments and PP&E	—			—		—		(100.1		)	(100.1		)	—			(100.1		)
Proceeds from short-term investments	—			—		—		57.8			57.8			—			57.8
Proceeds received on sale of product rights	—			—		—		127.0			127.0			—			127.0
Proceeds from disposal of non-current investments and PP&E	—			—		—		21.5			21.5			—			21.5
Other, net	—			—		—		0.2			0.2			—			0.2
Net cash provided by (used in) investing activities	(1,900.0		)	—		—		(3,572.3		)	(3,572.3		)	1,441.7			(4,030.6		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving line of credit, long term and short term borrowings	2,310.0			—		—		0.8			0.8			—			2,310.8
Repayment of revolving line of credit, long term and short term borrowings	(1,460.0		)	—		—		(1.8		)	(1.8		)	—			(1,461.8		)
Repayment of debt acquired through business combinations	—			—		—		(551.5		)	(551.5		)	—			(551.5		)
Proceeds from ViroPharma call options	—			—		—		346.7			346.7			—			346.7
Proceeds from intercompany borrowings	(458.3		)	—		—		1,900.0			1,900.0			(1,441.7		)	—
Payment of dividend	(8.9		)	—		—		(112.3		)	(112.3		)	—			(121.2		)
Debt issuance costs	(10.6		)	—		—		0.4			0.4			—			(10.2		)
Contingent consideration payments	—			—		—		(15.2		)	(15.2		)	—			(15.2		)
Proceeds from exercise of options	15.2			—		—		2.2			2.2			—			17.4
Other, net	—			—		—		39.5			39.5			—			39.5
Net cash provided by / (used in) financing activities	387.4			—		—		1,608.8			1,608.8			(1,441.7		)	554.5
Effect of foreign exchange rate changes on cash and cash equivalents	—			—		—		(9.3		)	(9.3		)	—			(9.3		)
Net increase in cash and cash equivalents	—			—		—		743.0			743.0			—			743.0
Cash and cash equivalents at beginning of period	—			—		—		2,239.4			2,239.4			—			2,239.4
Cash and cash equivalents at end of period	$	—		$	—	$	—	$	2,982.4		$	2,982.4		$	—		$	2,982.4